| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.15B | +8.6% |
| Cost of Revenue | $2.11B | +4.8% |
| Gross Profit | $2.04B | +12.7% |
| R&D Expense | $942.8M | -12.6% |
| SG&A Expense | $468.5M | -9.5% |
| Operating Income | -$876.5M | +27.3% |
| Pre-tax Income | -$996.7M | +19.9% |
| Income Tax | $18.7M | +49.5% |
| Net Income | -$1.02B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $655.9M | +0.6% |
| Accounts Receivable | $562.8M | +2.8% |
| Current Assets | $4.90B | -1.6% |
| Total Assets | $11.61B | -7.6% |
| Current Liabilities | $738.3M | -8.6% |
| Long-term Debt | $989.0M | +0.2% |
| Total Liabilities | $1.88B | -6.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $414.8M | +263.1% |
| Investing Cash Flow | $228.6M | +137.1% |
| Financing Cash Flow | -$643.6M | -1530.0% |
| +19.2% |
| EPS (Basic) | -$5.54 | +19.2% |
| EPS (Diluted) | -$5.54 | +19.2% |
| Stockholders' Equity |
| $9.73B |
| -7.8% |